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Abstract 
RHOBTB3 is one of the three members of the 
RhoBTB family. All RhoBTB proteins are 
characterized by a GTPase domain followed by a 
proline-rich region, a tandem of two BTB domains 
and a C-terminal putative RING finger domain. In 
RHOBTB3 the GTPase domain has ATPase activity. 
RHOBTB3 is a putative tumour suppressor gene. 
Expression of RHOBTB3 has been found 
significantly decreased in the breast, kidney, uterus, 
lung, and ovary tumors and in human renal 
carcinomas. The mechanism of RHOBTB3 protein 
as a tumor suppressor may be related to its function 
as an adaptor of cullin 3-dependent ubiquitin ligases. 
RHOBTB3 targets cyclin E for degradation and 
facilitates entry into the G2 phase of the cell cycle. 
RHOBTB3 also builds a multiprotein complex that 
maintains HIFα (hypoxia inducible factor α) levels 
low by promoting its hydroxylation, ubiquitination 
and degradation. 
Keywords 
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Identity 
HGNC (Hugo): RHOBTB3 
Location: 5q15 
Location (base pair): Starts at 95,713,522 bp from 
pter and ends at 95,824,383 bp from pter. 
DNA/RNA 
Description 
The RHOBTB3 gene spans over 65 Kbp genomic 
DNA and consists of 12 exons. The first exon splits 
the translation initiation codon (Figure 1). The 
coding sequence of RHOBTB3 is 1833 nucleotides 
long (Ramos et al., 2002). 
Transcription 
There is no evidence of transcription variants. 
Protein 
Note 
RHOBTB3 is one of the three members of the 
RhoBTB family in vertebrates. The RhoBTB family 
was identified during the study of the genes encoding 
Rho-related proteins in the lower eukaryote 
Dictyostelium discoideum (Rivero et al., 2002). All 
three RhoBTB proteins may be implicated in 
tumorigenesis (Berthold et al., 2008b). 
Description 
RHOBTB3 is 611 amino acids long. All RhoBTB 
proteins share the same domain architecture: a 
GTPase domain is followed by a proline-rich region, 
a tandem of two BTB domains and a C-terminal 
region (Figure 2). 
The GTPase domain of RHOBTB3 is considerably 
divergent and unlike the GTPase domain of 
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RHOBTB1 and RHOBTB2, which bind GTP, it 
binds and hydrolyses ATP (Espinosa et al., 2009).  
The proline-rich region links the GTPase to the first 
BTB domain. In RHOBTB1 and RHOBTB2 this 
region could act as a SH3 domain-binding site, 
however in RhoBTB3 the proline-rich region is not 
very prominent.  
The BTB domain (broad complex, tramtrack and 
bric-a-brac) is an evolutionary conserved protein-
protein interaction domain that participates in 
homomeric and heteromeric associations with other 
BTB domains. The BTB domain was also identified 
as a component of multimeric cullin 3-dependent 
ubiquitin ligase complexes. The first BTB domain is 
bipartite, being interrupted by an insertion of 
unknown function that is much shorter in RhoBTB3 
than in the two other members of the family. The 
BTB domains of RhoBTB allow the formation of 
homodimers and of heterodimers with other proteins 
of the RhoBTB family (Berthold et al., 2008).  
The C-terminus is a region conserved in all members 
of the RhoBTB subfamily. It predictably folds as 4 
consecutive alpha-helices and one beta-strand and 
may constitute a RING finger domain (Manjarrez et 
al., 2014). Many RING finger domains function as 
ubiquitin ligases. RHOBTB3 bears a CAAX motif 
that is typical for classical Rho GTPases. This motif 
undergoes isoprenylation of the cysteine residue and 
proteolytic cleavage of the last three residues and 
serves for localization of the protein to membranes, 
although it's not the only determinant for the Golgi 
apparatus targeting of RHOBTB3 (Lu and Pfeffer, 
2013). 
Expression 
RHOBTB3 is ubiquitously expressed, with high 
mRNA levels present in placenta, testis, pancreas, 
adrenal and salivary glands and neural and cardiac 
tissues. It is also expressed in fetal tissues (Ramos et 
al., 2002; Nagase et al., 1998).  
Expression of the mouse Rhobtb3 gene has been 
investigated in great detail in a gene trap mouse 
strain that expresses β-galactosidase under the 
control of the endogenous Rhobtb3 promoter (Lutz 
et al., 2014). Histochemical detection of β-
galactosidase expression revealed a profile 
characterized by nearly ubiquitous expression of 
Rhobtb3 in the embryo, with particularly high levels 
in bone, cartilage, all types of muscle, testis and 
restricted areas of the nervous system. In the adult 
mouse expression declines considerably, but persists 
at low levels in cardiac muscle, the tunica media of 
blood vessels, the muscularis of hollow organs and 
cartilage, and at high levels in the seminiferous 
tubules and peripheral nerves.  
Expression of RHOBTB3 has been found decreased 
in kidney, breast, uterus, lung and ovary tumors in a 
cancer profiling array (Berthold et al., 2008) and in 
diverse renal cell carcinoma subtypes (Zhang et al., 
2015). 
Localisation 
The localisation of endogenous RHOBTB3 has not 
been investigated. Available antibodies fail to 
recognise any endogenous RHOBTB3 in fixed cells 
and tissues. In cells expressing epitope tagged 
RHOBTB3 ectopically the protein tends to form 
aggregates in a paranuclear pattern (Berthold et al., 
2008). When expressed at moderate levels 
RHOBTB3 displays a vesicular pattern 
predominantly surrounding the centrosome. 
RHOBTB3 co-localises with Golgi apparatus 
markers. Some vesicles co-localize with early 
endosome markers or in close vicinity to 
microtubules or stress fibres (Berthold et al., 2008; 
Espinosa et al., 2009). 
Function 
Following functions have been proposed for 
RHOBTB3. The molecular mechanisms by which 
RhoBTB3 exerts those roles are beginning to be 
elucidated and in most cases may be related to its 
role in ubiquitination.  
1. RHOBTB3 as adaptor of cullin 3-dependent 
ubiquitin ligases.  
The first BTB domain binds to the N-terminal region 
of CUL3 (cullin 3), but not other cullins. RHOBTB3 
is itself a substrate for the cullin 3-based ubiquitin 
ligase complex (Berthold et al., 2008). RhoBTB 
proteins appear to exist in an inactive state through 
an intramolecular interaction of the BTB domain 
region with the GTPase domain (Berthold et al., 
2008).  
Several potential substrates of RHOBTB3-
dependent ubiquitin ligase complex have been 
described, including LRRC41 (MUF-1) and cyclin E 
and RHOBTB3 also participates in the degradation 
of HIF1A (HIFα hypoxia inducible factor α). They 
have implications in tumorigenesis and are described 
below.  
RHOBTB3 also interacts with the 5-HT7a receptor, 
the most common splice variant of HTR7, the 
serotonin receptor 7. This receptor is involved in a 
wide variety of pathophysiological processes of the 
central nervous system. Interestingly, the 5-HT7a 
receptor appears to interact with cullin 3 
independently of RHOBTB3, and RHOBTB3 
apparently inhibits proteasomal degradation of the 
receptor (Mathys et al., 2012)  
2. RHOBTB3 roles in cell cycle regulation and 
tumorigenesis.  
RHOBTB3, like RHOBTB1 and RHOBTB2, 
interacts with MUF1 (LLRC41, leucine rich repeat 
containing 41). MUF1 is a nuclear protein and 
carries a BC-box that functions as a linker in 
multicomponent cullin 5-dependent ubiquitin ligase 
complexes (Schenkov et al., 2012). MUF1 may be a 
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substrate for RhoBTB-Cullin 3 ubiquitin ligase 
complexes. The function of MUF1 is unknown, but 
it is suspected to be involved in the DNA damage 
response.  
RHOBTB3 binds cyclin E1 (CCNE1) (and to a lesser 
extent CCNB1 (cyclin B1)), uncoupled from its 
dependent kinaseCDK2. Cyclin E regulates the cell 
cycle transition from G1 to S phase and is degraded 
before entry into G2 phase. RHOBTB3 targets cyclin 
E for ubiquitination by a cullin 3-dependent 
ubiquitin ligase that localizes at the Golgi apparatus 
(Lu and Pfeffer, 2013). RhoBTB3 protein 
accumulates during the S phase after the plateau of 
cyclin E. Depletion of RHOBTB3 causes S-phase 
arrest in cultured cells accompanied by increased 
levels of cyclin E and increased activity of CDK2. 
Therefore RHOBTB3 regulates the S/G2 transition 
of the cell cycle by targeting cyclin E for 
ubiquitination. The RHOBTB3-CUL3 pathway 
constitutes an alternative ubiquitination route to the 
KITLG (SCF)- FBXW7 pathway, but these two 
pathways may target different pools of cyclin E. This 
mechanism may contribute to the role of RHOBTB3 
as a tumor suppressor. Deregulation of cyclin E 
levels can have a significant impact on cell 
proliferation, as shown in a significant percentage of 
breast cancers where high cyclin E correlates with 
tumor stage and grade.  
Regulation of HIFα levels constitutes another case of 
cross-talk between different ubiquitination 
pathways. HIFs are key regulators of adaptive 
responses to low oxygen concentration. In the 
presence of oxygen their α-subunits are rapidly 
degraded through an ubiquitination-dependent 
proteasomal pathway after hydroxylation. Under 
hypoxia conditions HIFs accumulate and bind to 
hypoxia responsive elements of various genes, in 
many cases related to aspects of cancer growth. In 
fact, aberrant accumulation or activation of HIFs is 
closely linked to many types of cancer. 
Hydroxylated HIFα is targeted for ubiquitination by 
the von Hippel-Lindau (VHL) protein, a component 
of a CUL2 (cullin 2)-dependent ubiquitin ligase 
(Tanimoto et al., 2000).  
RHOBTB3 acts as a scaffold for a multicomponent 
complex that regulates the degradation of HIFα. 
RHOBTB3 binds the prolyl hydroxylase EGLN1 
(PHD2) that promotes hydroxylation of HIFα 
(Zhang et al., 2015). The complex also binds VHL 
protein and facilitates ubiquitination of HIFα. 
Additionally RHOBTB3 appears to heterodimerize 
with LIMD1, an adaptor for PHD2 and VHL, and 
this interaction enhances the activity of the complex. 
The chaperone HSP90AA1 (Hsp90) is incorporated 
to the complex through interaction with HIFα and 
does not seem to interact with RHOBTB3. Hsp90 
may contribute to relieve the autoinhibitory 
conformation of RHOBTB3, as it has been proposed 
for RHOBTB2 (Manjarrez et al., 2014). Hypoxia 
reduces the formation of the RHOBTB3-dependent 
multicomponent complex, resulting in an 
accumulation of HIFα.  
A tumor suppressor role for RHOBTB3 has been 
shown in xenograft experiments with Ras-
transformed embryonic fibroblasts isolated from 
Rhobtb3 deficient mice or HeLa cells in which 
Rhobtb3 was silenced. The xenografts were larger 
and had increased levels of HIFα and its gene targets. 
It has been proposed that RHOBTB3 inhibits 
tumorigenesis by maintaining low HIFα levels and 
consequently suppressing the Warburg effect (Zhang 
et al., 2015).  
3. RHOBTB3 and vesicle trafficking.  
RHOBTB3 is a component of a complex required for 
retrograde transport to the Golgi complex that 
contains RAB9A and the cargo selection protein 
PLIN3 (TIP47), with which RHOBTB3 interacts 
(Espinosa et al., 2009). When RHOBTB3 is depleted 
by gene silencing the Golgi apparatus becomes 
fragmented (Lu and Pfeffer 2013) and the mannose-
6-P receptor adopts a disperse localization in Rab9 
positive vesicles, indicative of altered retrograde 
transport, but endocytosis and exocytosis are not 
changed (Espinosa et al., 2009). A model has been 
proposed in which Rab9 on vesicles travelling from 
late endosomes to the Golgi relieves the 
autoinhibitory conformation of RHOBTB3 and 
allows maximal ATP hydrolysis. Activation of 
RHOBTB3 releases TIP47, facilitating vesicle 
uncoating and membrane fusion (Pfeffer 2009).  
4. Other roles.  
A case of a male carrying a balanced paracentric 
inversion of chromosome 5 that disrupts RHOBTB3 
has been reported. This patient showed asymmetric 
leg growth and large hands and behavior problems. 
It hasn't been determined whether disruption of 
RHOBTB3 is the cause of those alterations (Chen et 
al., 2010).  
The characterization of a gene trap knockout mouse 
strain has shown that disruption of the Rhobtb3 gene 
causes reduced perinatal viability, a postnatal growth 
defect that persists in males after weaning and 
reduced testis size (Lutz et al., 2014). Ablation of 
Rhobtb3 only caused very modest changes in the 
pattern of gene expression of adult heart and brain. 
Lack of Rhobtb3 did not affect the rate of 
proliferation of primary lung fibroblasts isolated 
from 10-week-old animals (Lutz et al., 2014) but 
higher proliferation rates have been reported in 
mouse embryonic fibroblasts (Zhang et al., 2015).  
RHOBTB3 has been identified as a candidate blood 
biomarker for hallucinations. Gene expression was 
found decreased in high hallucination states (Kurian 
et al., 2011). RHOBTB3 has also been proposed as a 
candidate vulnerability gene for Alzheimer's disease 
(Miller et al., 2013).  
Like other members of the RhoBTB family, 
RHOBTB3 has no apparent influence on cell 
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morphology and actin organization (Berthold et al., 
2008). 
Homology 
There are three RhoBTB proteins in vertebrates: 
RHOBTB1, RHOBTB2 and RhOBTB3 (Figure 2). 
RHOBTB2 is very similar to RHOBTB1, while 
RHOBTB3 displays very low similarity to these. 
Orthologues have been found in amoebae and in 
insects but they are absent in plants and fungi. 
Mutations 
No pathogenic mutations have been identified to 
date. 
Implicated in 
Various cancers, including kidney, 
breast, uterus, lung and ovary 
Expression of RHOBTB3 was found moderately but 
significantly decreased in breast, kidney, uterus, 
lung, and ovary tumour samples in a cancer profiling 
array. The decrease affected to 80% of kidney and to 
56% of breast cancer samples. The expression 
changes correlated with those of CUL3 in the same 
samples (Berthold et al., 2008) 
Renal cell carcinoma 
RHOBTB3 expression is significantly decreased in 
clear cell renal cell carcinoma, papillary renal cell 
carcinoma, hereditary clear cell renal cell carcinoma 
and non-hereditary clear cell renal cell carcinoma 
subtypes (Zhang et al., 2015). 
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